MedPath

SEAFORD NIFEDIPINE AND LIDOCAINE HYDROCHLORIDE CREAM

SEAFORD NIFEDIPINE AND LIDOCAINE HYDROCHLORIDE CREAM

Approved
DIN Number

02548283

Drug Class

Human

Market Date

N/A

Company
HC

seaford pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02548283
AIG Number0265923001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C05AD01 LIDOCAINE
Product Specifications
Dosage FormCream
Route of AdministrationRectal
AHFS Classification72:00.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

LIDOCAINE HYDROCHLORIDEActive
Strength: 1.5 % / W/W
Monograph: LIDOCAINE HYDROCHLORIDE
NIFEDIPINEActive
Strength: 0.3 % / W/W
Monograph: NIFEDIPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.